InsiderClue
Insiders · Profile

TETRAULT LYNN A.

Director at RHYTHM PHARMACEUTICALS · Director at NEOGENOMICS. Filing since 7 Dec 2015. CIK 0001645512

RYTM RHYTHM PHARMACEUTICALS, INC. Director · 5 trades NEO NEOGENOMICS INC Director · 8 trades
Company
Date
Role
Action
Shares
Amount
Of holding
RYTM RHYTHM PHARMACEUTICALS, INC.
22 Jun 2026
Director
Sold on a plan
37,000
$3.71M
84.1%
NEO NEOGENOMICS INC
15 Jun 2026
Director
Sold on a plan
5,307
$58.91K
5.8%
NEO NEOGENOMICS INC
9 Jun 2026
Director
Sold on a plan
5,307
$59.92K
5.5%
NEO NEOGENOMICS INC
9 May 2025
Director
Bought
7,000
$56.97K
opened
RYTM RHYTHM PHARMACEUTICALS, INC.
10 Sep 2024
Director
Sold on a plan
17,501
$868.92K
85.4%
RYTM RHYTHM PHARMACEUTICALS, INC.
9 Sep 2024
Director
Sold on a plan
3,199
$160.07K
51.6%
RYTM RHYTHM PHARMACEUTICALS, INC.
26 Aug 2024
Director
Sold on a plan
4,300
$215.03K
58.9%
RYTM RHYTHM PHARMACEUTICALS, INC.
12 Aug 2024
Director
Sold on a plan
10,000
$446.46K
76.9%
NEO NEOGENOMICS INC
4 Mar 2024
Director
Sold on a plan
6,112
$97.58K
10.9%
NEO NEOGENOMICS INC
19 Nov 2018
Director
Sold, plan not stated
13,000
$207.94K
25.4%
NEO NEOGENOMICS INC
14 Nov 2018
Director
Sold, plan not stated
5,000
$80.80K
8.9%
NEO NEOGENOMICS INC
21 Dec 2015
Director
Bought
9,500
$78.00K
188%
NEO NEOGENOMICS INC
7 Dec 2015
Director
Bought
3,500
$27.02K
224%
13 decisions on file.